Abstract Monoclonal antibodies (McAbs) against chloramphenicol (CAP) were produced to detect CAP residues, which could be toxic and possesses a potential threat to human health. The CAP-BSA conjugate was obtained by bovine serum albumin (BSA) coupled with CAP, and used to immunize the mice. The splenocytes from the immunized mice were fused with mouse myeloma cells SP2/0 to form hybridoma, which may secrete McAbs against CAP. Hybridomas 1D 1 and 3G 12 secreting McAbs against CAP were obtained by screening. Ascites containing McAbs were prepared by injecting 1 x 10 6 cells of hybridoma 1D 1 and 3G 12 into the abdomen of mice. Protein A affinity chromatography was used to purify McAbs against CAP in a single chromatographic step with recovery yield above 80% and purity above 95% and full recovery of antibody activity. Experiments showed that McAb 3G 12 was highly specific for CAP and had no cross-reactivity with analogues which have a structure similar to CAP. The IC 50 value was 50.8 ng/mL.
Introduction
Chloramphenicol (CAP), a highly active, broad-spectrum antibiotic produced by Streptomyces venezuelae ( Van de Water and Haagsma 1987; Jeya Shakila et al. 2007) , has satisfactory inhibition on Gram-negative and Gram-positive bacteria (Sorensen et al. 2003) . Since CAP was first isolated in 1947 (Volini et al. 1950) , it had been used clinically for the treatment of bacteriosis and it had been used as a feed additive in animal breed and aquaculture because of its, excellent antibacterial and stable medicinal properties and low price (Holt et al. 1993; Turton et al. 1999; Farombi 2001) .
However, some cacoethic effects caused by the serious toxicity of CAP, such as agranulocytosis, aplastic anaemia (Franklin and snow 1989) and gray baby syndrome (Allen 1985) , had been discovered. Moreover, long term use of small dose can result in imbalance of normal microbiota, so people could be infected easily by various kinds of microorganisms (Allen 1985) . The Joint FAO/WHO Expert Committee on Food Additives (JFCFA) had concluded that chloramphenicol was genotoxic and could cause genetic damages, possibly cancer (Anon 2002) , so the US banned its use in foods and biofeeds in 1994. Chloramphenicol was placed in Annex IV of the Council Regulation EEC No. 2377/90 and is not allowed to be employed in the production of food (Hanekamp 2002) . The EU forbade its employment in 1996. In India, the Marine Products Export Development Authority banned the use of chloramphenicol in food-producing animals in 2002 (MPEDA 2002) . Thus, using the sensitive approaches to monitor and enforce the implementation of zero-tolerance level of CAP seems very crucial. According to the literature, the methods for analysis and detection of CAP residues in animal tissues have included chromatography (Hanekamp 2002) , microbiological assays, immunoassay, mass spectrometry (Pfenning et al. 2000; Gaudin and Maris 2001; Zhang et al. 2008 ) and chromatography/mass spectrometry (Bononi and Tateo 2008) . Microbiological assays lack the necessary sensitivity, while chromatography and mass spectrometry need a lot of time for preparing samples (Fergusona et al. 2005) . Immunoassay is a method of high sensitivity and specificity, simple operation and low cost, so far it has been the optimal method for routine detection of CAP residues in animal tissues, but it is most important for immunoassay that reaction between antibody and antigen has high specificity and sensitivity. So preparation of highly specific McAbs against CAP will be helpful for the detection of residual CAP in food-producing animals. In this study, we report the preparation and purification of highly specific monoclonal antibodies against CAP, which used purified CAP-BSA as immunogen. This paper provides an experimental basis for detection of residual CAP in food-producing animal.
Materials and methods

Materials
BALB/c mouse and F1 mouse were provided by Zhejiang Animal Experiment Center (Hangzhou China). SP2/0 myeloma cell lines were purchased from NanJing KeyGen BioTech Co. Ltd (NanJing China). CAP was obtained from Aladdin (Shanghai, China). Bovine serum albumin (BSA), ovalbumin (OVA), Freund's adjuvant, Hypoxanthine/aminopterin/thymidine (HAT) and hypoxanthine/thymidine (HT) were purchased from Sigma (USA Preparation of CAP-BSA and CAP-OVA BSA or OVA was conjugated to CAP according to the method described by Erlanger (1980) . 500 mg CAP were dissolved in 15 mL of absolute ethanol. The solution was adjusted to pH 1 with concentrated HCl, and 400 mg zinc powder was added and than incubated for 1 h at 65°C under stirring. The solution was adjusted to pH 2.0 by adding concentrated HCl slowly with stirring on ice followed by dropping 1 mol/L NaNO 2 solution until the potassium iodidestarch test paper turned into blue. The CAP solution was adjusted to pH 8 with 0.2 mol/L NaOH, and slowly added to the BSA solution (which consisted of 500 mg BSA and 10 mL of 20 mmol/L, PBS pH 8.0) under stirring. The reaction was then incubated overnight at 4°C. Purified CAP-BSA/CAP-OVA was achieved by gel filtration using Sephadex G-25 column, then stored at -20°C after freeze-drying.
Immunization 10 mg CAP-BSA conjugate as immunogen was dissolved in 0.9% normal saline (10 mL). 100 lL solution of CAP-BSA was completely emulsified with an equal volume of Freund's complete adjuvant and administered subcutaneously. Each mouse was injected with 100 lg of CAP-BSA every time. One week after the first injection, the next two immunizations were performed with Freund's incomplete adjuvant instead of Freund's complete adjuvant at a weekly interval. Three days before cell fusion, the last boosting injection was carried out with 100 lL of 1 mg/mL solution of CAP-BSA in 0.9% normal saline by intraperitoneal injection (Dong et al. 2006; Xuan et al. 1999 ).
Preparation of hybridoma
Three days after the final boosting injection, the mouse was sacrificed and the splenocytes were isolated from spleen and hybridized with SP2/0 myeloma cells, a HAT-sensitive mouse myeloma cell line, at a ratio of 5:1 by 50% polyethylene glycol (M = 1,500). Fused cells were suspended in RPMI-1640 Medium contained 20% FCS and HAT, then added (200 lL per well) to 96-well tissue culture plates, and cultured in 5% CO 2 incubator. One week after incubation, the hybridomas were screened by an indirect ELISA and the positive hybridomas were re-screened using an indirect competitive ELISA (ciELISA) with CAP as the competitor. CAP-OVA conjugate was employed as coating antigen. The hybridomas that excreted specific antibodies to CAP were subcloned by the limiting dilution method. The hybridomas producing McAbs against CAP were transferred from the culture in the 96-well plate to a 24-well plate in 0.6 mL of culture medium. After hybridomas became dense in the 24-well plate, they were transferred to cell culture flasks. Hybridoma cells were collected, centrifuged, propagated and frozen (overnight at -80°C in liquid nitrogen) in culture medium containing 10% dimethyl sulphoxide and stored in liquid nitrogen.
ELISA procedure
Indirect ELISA tests were carried out using the following procedure; 100 lL 1 lg/100 lL coating antigen CAP-OVA conjugate dissolved in coating buffer of 0.02 mol/L pH 7.4 phosphate buffer was added to a microtiter plate and incubated overnight at 4°C. Plates were washed three times using 200 lL/well of washing buffer solution containing 0.1% Tween-20 in phosphate buffer and 100 lL antibody diluted with PBS was added to each well. Unbound compounds were removed by washing solution after incubation for 1 h at 37°C. 100 lL HRP-IgG was added to each well for 1 h at 37°C then washed three times with washing buffer. 100 lL of orthophenylenediamine (OPD) substrate solution, was added to each well and the enzymatic reaction was stopped after 5 min incubation at 37°C by addition of 100 lL/well of 2 mol/L H 2 SO 4 as stopping solution. Then absorbance values were measured at 490 nm (Gao et al. 2007 ). The ciELISA procedure was similar to that of indirect ELISA, except adding the same volume of 50 lL of CAP standard solution and 50 lL of antibody to every well (Gao et al. 2007 ).
Large-scale preparation of McAbs against CAP in vivo
McAbs against CAP were prepared at large-scale by preparation of ascites in vivo. One week after intraperitoneal injections with 0.5 mL liquid paraffin, an 8-weeks-old F1 mouse was planted with 1 9 10 6 hybridoma cells by intraperitoneal injection. The ascites were collected as many times as possible 1 week later.
Measurement of ascites titer
According to the indirect ELISA described above, microtiter plates were coated with the 100 lL of 1 lg/ 100 lL of CAP-OVA in coating buffer, serial dilution of ascites (10 -1 , 10 -2 , 10 -3 , 10 -4 , 10 -5 , 10 -6 , 10 -7 , 10 -8 ) was pipetted into microtiter plates. The absorbance value was detected at 490 nm using a microplate reader. And the best ascites titer (10 -7 ) was determined: In this experiment, the ascites titer for the well with an absorbance of 1.0 was defined as the best ascites titer.
Purification of McAbs
Purification of McAbs was carried out by protein A affinity chromatography. 0.5 mL ascitic fluid was diluted with an equal volume of starting buffer, and loaded onto the column equilibrated at a flow rate of 5 mL/min with 20 mmol/L phosphate buffer. After elution of the unbound material, the eluent was changed to 0.1 mol/L glycin-HCl buffer (pH 7.0) to elute the bound material. Choosing pH and ionic strength of starting buffer, and pH of eluent was determined by the efficiency of purification. Finally it was washed with 20% (v/v) ethanol, as a regeneration step to remove the nonspecifically adsorbed material from the resin and preserve chromatographic column. The bound fraction was collected, immediately neutralized with a few drops of 1 mol/L Tris (pH 9.0), and desalted by ultrafiltration. The desalted protein was characterized by SDS-PAGE and Gel imaging system to determine IgG purity and recovery yield and by enzyme-linked immunosorbent assay (ELISA), to evaluate the immuno-reactivity.
Assessment of protein concentration and SDS-PAGE
Protein concentration was determinated by Coomassie brilliant blue G-250. Pure BSA was used as standard to measure the protein concentration of ascites. Coomassie brilliant blue G-250 were added to BSA standards of different concentration (0, 0.02, 0.04, 0.06, 0.08, 0.1 mg/ml), then the absorbance of different standard concentrations was measured at 595 nm after 5 min. A linear standard curve was obtained by plotting the absorbance. The protein concentration of ascites and elution were calculated by linear standard curve.
The purity of McAbs separated from affinity columns was checked by SDS-PAGE analysis. The size of the gels was 7 9 6 cm with a thickness of 0.75 mm. The acrylamide volume in the collecting gel was 5% and in the separation gel 10%. Gels were run at a constant voltage of 80 V and at room temperature. The running buffer contained 25 mmol/L Tris, 200 mmol/L glycine and 0.1% SDS (pH 8.3). Samples were mixed with DTT (reducing buffer) at a ratio of 1:1 and were heated to 95°C for 5 min in a water bath. After the run the gel was stained with Coomassie brilliant blue R-250, the stained gels were analyzed by digital image processing to assess the purity (D' Agostino et al. 2008 ).
Assessment of antibody specificity
The cross-reactivity of ascites antibody to various other similar drugs was tested using an indirect competitive ELISA as described above, which was determined by measuring their IC 50 values in the ciELISA using the midpoint of the CAP standard curve in all cases. The IC 50 values (50% inhibition levels) were used for calculation of cross-reactivity (CR 50 %) as follows: CR 50 % = 100 9 IC 50 value of CAP/IC 50 value of competitor (Gao et al. 2007 ).
Results and discussion
Preparation of CAP conjugates CAP must be conjugated to a carrier protein to elicit an immune response. Using diazotization method, it could be linked to protein carriers through the peptide linkage. When UV detection, it could be confirmed that CAP-BSA was produced successfully. Results are shown in the Fig. 1 , that the k max of BSA was 278 nm, k max of CAP was 277 nm. However, k max of CAP-BSA was 275 nm, which had a hypsochromic shift. UV absorption of CAP-BSA was significantly higher than that of BSA at an equal protein concentration.
Titer of CAP antibody of mice serum before cell fusion Four BALB/c mice were immunized with CAP-BSA, then the titer of CAP antibody was detected in the mouse sera (Table 1 ). The titer of CAP antibody of the four mouse sera was over 10 -6 .
Preparation of hybridoma
Hybridoma cells 1D 1 and 3G 12 of anti-CAP were rescreened and subcloned four times by limiting dilution. The ratio of positive wells was determined by ELISA (Table 2) . Two cell lines could still stably secrete specific McAbs against CAP after liquid nitrogen freeze-storage.
Assessment of titer and protein content of cell supernatant and ascites
The titer and protein content of cell supernatant and ascites were detected by ELISA and Coomassie brilliant blue assay, respectively (Table 3 ). The results showed that, when the titer of the cell culture supernatant was 10 -4 and the ascites titer was 10 -7 , Fig. 1 UV scanning of CAP-BSA the protein concentrations were up to 6 mg/ml and 36 mg/ml, respectively.
Purification of monoclonal antibody
Researches have shown that McAbs were retained by the chromatography medium with a 20 mmol/L Na phosphate buffer as loading buffer (pH 6.5, 7.0, 7.5). Under loading condition of pH 7.0, McAbs was most stable and the elution peak of McAbs contained less impure protein contamination than at pH 6.5 or 7.5. Therefore, pH 7.0 was considered as the optimal loading buffer. Ionic strength of loading buffer has a certain effect on the final purity of McAbs. When the ionic strength was 0-3mol/L NaCl, mcAbs were retained by the chromatography medium. Under a ionic strength of 3.0 mol/L NaCl, the purity of McAbs was higher.
0.1 mol/L glycine-hydrochloric acid buffer was chosen as an eluent, and elution was carried out as a single-step. Experimental results showed that under pH of 2.5, 3.0 and 3.5, antibody was well separated from contaminants. The increase of pH, gradually improved the resolution and the antibody peak and contaminating protein peak were completely separated. Purity of purpose antibody was more than 95%. But with the increase of the pH, the recovery of antibody was reduced. Therefore, the 0.1 mol/L glycine-hydrochloric acid buffer (pH 3.0) was retained as eluent.
Results presented in Fig. 2 showed, that a 20 mmol/ L PB ? 3.0 NaCl mol/L (pH 7.0), and 0.1 mol/L glycine-hydrochloric acid buffer (pH 3.0) were the best loading and elution conditions, respectively, impurity flew through the chromatographic column, whereas antibody was removed by eluent. So the antibody peak and contaminating protein peak were completely separated. Electrophoresis appraisal results are shown in Fig. 3 , that in the elution peak, two major protein bands can be found, with molecular weights of 55, 25 kDa, which are the two chains of the antibody. Purity and recovery of antibody can reach up to 95 and 80%, the biological activities were also good.
Monoclonal antibody specificity
Antibody sensitivity was determined by the ciELISA under the optimal concentration of the coating antigen and McAbs. Figure 4 illustrates a typical 3G 12 standard curve, with IC 50 of 50.3 ng/mL.
It was important for McAbs to detect crossreactivity of the applied antibody. Therefore, a number of compounds related to chloramphenicol, such as thiamphenicol, sulfadimidine, chloramphenicol sodium succinate, were tested with ciELISA to characterize the properties of the antibody. Their corresponding cross-reactivities are shown in Table 4 . The data demonstrated that 3G 12 monoclonal antibody was highly specific for CAP.
Conclusion
Monoclonal antibody is a kind of immunoglobulin, with high specificity and biological activity (Dirnhofer The results of the experiments are consistent with the expectation of the designed antigen in vitro. We adopted Protein A affinity chromatography to purify ascites for its good efficiency of separation, including high purity and specificity, good biological activity, easy operation, quickness and repeatability. By using Protein A affinity chromatography McAbs were captured in a single chromatographic step with a recovery yield above 80% and a purity degree above 95% and full recovery of antibody activity. The crossreactivity assay showed that monoclonal antibodies secreted by 3G 12 cells have no cross-reactivity with BSA, thiamphenicol and sulfadimidine. The structure of thiamphenicol is similar to CAP, the nitro group of Chloramphenicol is replaced by methylsulfonyl of thiamphenicol, which indicates that McAbs 3G 12 were highly specific for the nitro group of CAP. McAbs 3G 12 are suitable to develop an immunoassay for CAP (ELISA kit for CAP) with sufficient sensitivity for monitoring CAP residues. 
